发明名称 GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
摘要 The present invention provides compositions and methods based on genetic polymorphisms that are associated with coronary heart disease (particularly myocardial infarction), aneurysm/dissection, and/or response to drug treatment, particularly statin treatment. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.
申请公布号 US2017022563(A1) 申请公布日期 2017.01.26
申请号 US201615150636 申请日期 2016.05.10
申请人 Celera Corporation 发明人 IAKOUBOVA Olga;DEVLIN James J.;TONG Carmen;ROWLAND Charles
分类号 C12Q1/68;G01N33/68 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method for identifying a human who has an altered risk for developing CHD or aneurysm/dissection, comprising detecting a SNP in any one of the nucleotide sequences of SEQ ID NOS:1 and 3-132 or a complement thereof, in said human's nucleic acids, wherein the presence of the SNP is indicative of an altered risk for CHD or aneurysm/dissection in said human.
地址 San Clemente CA US